Vaso Active to Delist

Vaso Active Pharmaceuticals(VAPH Quote) on Thursday will pull its shares from the Nasdaq Stock Market indefinitely after learning that it is being investigated by the Food and Drug Administration and NASD.

The move, which comes a week after trading in the once highflying stock was suspended by the Securities and Exchange Commission, reflects the "substantial administrative and cash burdens" the company faces after hearing the concerns raised by the FDA and NASD over the past week. The SEC suspension had been scheduled to end April 15.

The SEC trading suspension followed a series of articles on this Web site noting inconsistencies in Vaso's clinical claims and troubling aspects of its pedigree. ...